Erik Deconinck

22PUBLICATIONS
127CO-AUTHORS
Haematological tumoursHaematologyMedical molecular engineering of nucleic acids and proteinsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Feb 11, 2026
Pivekimab Sunirine in Blastic Plasmacytoid Dendritic Cell Neoplasm.

Naveen Pemmaraju, Giovanni Marconi, Pau Montesinos

|Jun 19, 2025
Impact of fludarabine dose on outcome after allo-HSCT with reduced intensity conditioning for older patients with AML.

Guillaume Dachy, Myriam Labopin, Gérard Socié

|Dec 06, 2024
Venetoclax-proteasome inhibitor-dexamethasone for unfit patients with blastic plasmacytoid dendritic cell neoplasm.

Sabine Khalife-Hachem, Arnaud Pages, Elie Akoury

|Aug 21, 2024
Human Leukocyte Antigen Mismatching and Survival in Contemporary Hematopoietic Cell Transplantation for Hematologic Malignancies.

Esteban Arrieta-Bolaños, Edouard F Bonneville, Pietro Crivello

|Aug 05, 2024
Directionality of HLA-DP permissive mismatches improves risk prediction in HCT for acute leukemia and MDS.

Esteban Arrieta-Bolaños, Lars L J van der Burg, Tobias Gedde-Dahl

|May 31, 2024
Impact of scFv on Functionality and Safety of Third-Generation CD123 CAR T Cells.

Maxime Fredon, Margaux Poussard, Sabeha Biichlé

Pageof 4